Company Filing History:

9 out of 2,882

The General Hospital Corporation

patents

1 out of 1,370

The Brigham and Women's Hospital, Inc.

patents

1 out of 1

Enos Pharmaceuticals, Inc.

patent

where one patent can have more than one assignee

Years Active: 1995-2004

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6818669 - Increasing cerebral bioavailability of drugs (2004-11-16),

2. 6630347 - Endothelial NOS transgenic animals and methods of use (2003-10-07),

3. 6319955 - Use of MEK1 inhibitors as protective agents against damage due to ischemia (2001-11-20),

4. 6310270 - Endothelial NOS knockout mice and methods of use (2001-10-30),

5. 6150401 - Use of MEK1 inhibitors as protective agents against damage due to (2000-11-21),

6. 6147109 - Upregulation of Type III endothelial cell Nitric Oxide Synthase by (2000-11-14),

7. 5929061 - Method for treating vascular headaches (1999-07-27),

8. 5767117 - Method for treating vascular headaches (1998-06-16),

9. 5733871 - Methods for the treatment of neuronal damage associated with ischemia, (1998-03-31),

10. 5385940 - Treatment of stroke with nitric-oxide releasing compounds (1995-01-31),

Title: **Michael A Moskowitz: Innovator in Cerebral Drug Delivery**

Introduction

Michael A Moskowitz, located in Belmont, MA, is a distinguished inventor whose contributions have significantly advanced the field of medicine. With a notable portfolio of 10 patents, he has dedicated his career to innovating methods for enhancing drug delivery to the brain and understanding vascular disorders.

Latest Patents

Among his latest inventions, Moskowitz has developed a method for increasing cerebral bioavailability of drugs. This method outlines compositions designed to elevate nitric oxide (NO) levels in the brain, thereby enhancing cerebral blood flow. The increased flow facilitates the transport of drug molecules into brain tissue, making it possible to treat conditions that are typically resistant to standard drug delivery methods.

Furthermore, Moskowitz has patented technology related to endothelial nitric oxide synthase (eNOS) transgenic animals. These non-human animals, having a disrupted eNOS gene, display unique characteristics such as abnormal wound-healing properties and hypertension. His work not only introduces new models for screening therapeutic compounds for vascular diseases but also provides innovative methods for treating patients suffering from such conditions using identified compounds from these transgenic animals.

Career Highlights

Michael has held significant positions in prominent institutions, notably at the General Hospital Corporation and Brigham and Women's Hospital, Inc. His work at these prestigious establishments has formed the foundation for his innovative explorations in drug delivery and vascular health.

Collaborations

Throughout his career, Moskowitz has collaborated with esteemed colleagues such as James K Liao and Paul L Huang. These collaborations have played a vital role in advancing his research initiatives and patent developments.

Conclusion

Michael A Moskowitz exemplifies the spirit of innovation through his relentless pursuit of solutions to complex medical challenges. His patents are not only a testament to his scientific expertise but also a beacon of hope for future advancements in cerebral drug delivery and treatment for vascular disorders.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.